JPS5029578A - - Google Patents
Info
- Publication number
- JPS5029578A JPS5029578A JP7878073A JP7878073A JPS5029578A JP S5029578 A JPS5029578 A JP S5029578A JP 7878073 A JP7878073 A JP 7878073A JP 7878073 A JP7878073 A JP 7878073A JP S5029578 A JPS5029578 A JP S5029578A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7878073A JPS5029578A (ja) | 1973-07-11 | 1973-07-11 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7878073A JPS5029578A (ja) | 1973-07-11 | 1973-07-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5029578A true JPS5029578A (ja) | 1975-03-25 |
Family
ID=13671394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7878073A Pending JPS5029578A (ja) | 1973-07-11 | 1973-07-11 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5029578A (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022187206A1 (en) * | 2021-03-01 | 2022-09-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dual-target mu opioid and dopamine d3 receptors ligands; preparation and use thereof |
-
1973
- 1973-07-11 JP JP7878073A patent/JPS5029578A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022187206A1 (en) * | 2021-03-01 | 2022-09-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dual-target mu opioid and dopamine d3 receptors ligands; preparation and use thereof |